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Abstract The COLIA1 Sp1 polymorphism has been
associated with bone mineral density (BMD) and fracture.
A promoter polymorphism, -1997 G/T, also has been
associated with BMD. In this study, we examined whether
these polymorphisms alone and in the form of haplotypes
inﬂuence bone parameters and fracture risk in a large
population-based cohort of elderly Caucasians. We deter-
mined the COLIA1 -1997 G/T (promoter) and Sp1 G/T
(intron) polymorphisms in 6,280 individuals and inferred
haplotypes. Femoral neck BMD and BMD change were
compared across COLIA1 genotypes at baseline and fol-
low-up (mean 6.5 years). We also investigated the rela-
tionship between the COLIA1 polymorphisms and incident
nonvertebral fractures, which were recorded during a mean
follow-up period of 7.4 years. Vertebral fractures were
assessed by radiographs on 3,456 genotyped individuals.
Femoral neck BMD measured at baseline was 3.8% lower
in women carrying two copies of the T-Sp1 allele (P for
trend = 0.03). No genotype dependent differences in BMD
loss were observed. In women homozygous for the T allele
of the Sp1 polymorphism, the risk of fragility fracture in-
creased 2.3 times (95% conﬁdence interval 1.4–3.9, P =
0.001). No such association was observed with the pro-
moter polymorphism. In men, no association with either
the Sp1 or the -1997 G/T promoter polymorphism was seen
with BMD or fracture. High linkage disequilibrium (LD; D¢
= 0.99, r
2 = 0.03) exists between the two studied poly-
morphisms. We observed three haplotypes in our popula-
tion: haplotype 1 (Gpromoter–Gintron) frequency (f) = 69%,
haplotype 2 (Gpromoter–Tintron) f = 17.6%, and haplotype 3
(Tpromoter–Gintron) f = 13.4%. Haplotype 2 was associated
with a 2.1-fold increased risk of fragility fracture in women
(95% conﬁdence interval 1.2–3.7, P = 0.001). We conﬁrm
that the COLIA1 Sp1 polymorphism inﬂuences BMD and
the risk of fracture in postmenopausal Caucasian women.
In contrast, we found no independent effect of the -1997 G/
T promoter polymorphism on BMD or fracture.
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Introduction
Osteoporosis is a multifactorial disease with both genetic
and environmental determinants. It is characterized by a
reduction in bone mineral density (BMD) and microar-
chitectural deterioration of bone tissue, which leads to an
increased risk of fracture in later life [1, 2]. Being a pre-
dictor of bone fragility and susceptibility to fracture, BMD
is used for the diagnosis of osteoporosis [3, 4]. The risk of
fracture is dependent not only on BMD but also on
geometry, architecture, material properties, and mass dis-
tribution [5].
The skeletal determinants of osteoporotic fracture risk
such as BMD, bone loss, and bone geometry are all subject
to strong genetic inﬂuences [2, 6, 7]. It has been estimated
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attributable to genetic factors [8, 9]. Several genes are
thought to be involved in the pathogenesis of osteoporosis.
Collagen type I alpha 1 (COLIA1) is one of the most
prominent candidate genes, which has been consistently
associated with osteoporosis in different populations [10–
12]. COLIA1 encodes the alpha 1 chain of collagen type I,
which is the most abundant structural protein in the bone
matrix; rare mutations in this gene cause osteogenesis
imperfecta, a mendelian disorder presenting with moderate
to severe bone fragility [13, 14].
Previously, Grant et al. [15] identiﬁed a relatively
common guanine to thymidine (G ﬁ T) polymorphism in
the ﬁrst intron of COLIA1. This polymorphism affects one
of the binding sites of the transcription factor Sp1 and
results in increased expression of collagen type I alpha 1 in
bone matrix in T carriers [11] .We and others have shown
that the T allele is associated with osteoporosis, lower
BMD [10, 15], and increased fracture risk [10, 12, 16, 17].
Moreover, in a very large prospective meta-analysis of
individual data, we observed that the Sp1 polymorphism in
the COLIA1 gene is associated with reduced BMD and
incident vertebral fractures independent of BMD [18]. In
addition to the Sp1 polymorphism, Garcia-Giralt et al. [19]
described two polymorphisms within the COLIA1 promoter
region: -1997 G/T and -1663 indelT. The study showed in a
small cohort of postmenopausal Spanish women that the T
allele of the -1997 G/T polymorphism was signiﬁcantly
associated with a 7.5% decreased lumbar spine BMD and a
12% decreased femoral neck BMD. Furthermore, they
analyzed compound genotypes including three polymor-
phic sites. However, this small study of the promoter
polymorphisms in women investigated the relation in form
of compound genotypes, was not extended to haplotypes of
promoter and Sp1 polymorphisms, and most importantly,
did not analyze fractures, the clinically most relevant end
point of osteoporosis.
Therefore, we investigated the inﬂuence of both CO-
LIA1 polymorphisms independently and in the form of
haplotypes in relation to baseline femoral neck BMD,
change in BMD with follow-up, and risk of vertebral and
nonvertebral fractures in a large population-based cohort of
elderly Caucasian men and women.
Materials and Methods
Study Population
This study was embedded in the Rotterdam Study, a pop-
ulation–based cohort study in which all residents of the
Rotterdam suburb Ommoord aged 55 years and older were
invited to take part. The design of the study has been de-
scribed elsewhere [20]. Written informed consent was ob-
tained from all participants, and the Medical Ethics
Committee of the Erasmus Medical Center approved the
study. Baseline data collection was conducted in January
1990 and June 1993, while two follow-up assessments were
performed between July 1993 and January 1996 and from
July 1996 until December 1999. A total of 7,983 subjects
participated in the study (response rate 78%), and for the
present study, we examined 6,280 individuals who were
genotyped.
Study Design
This study was performed in three steps. In the ﬁrst step,
we performed a cross-sectional analysis where we
examined the relation between the genotype and baseline
BMD (n = 5,737). In the second step, we performed a
longitudinal analysis to study change in BMD between
baseline and the second follow-up (mean 6.5 ± standard
deviation [SD] 0.6 years, n = 2,670). In the third step, we
looked at the relation between COLIA1 polymorphisms
and the risk of incident fracture. We studied incidence of
nonvertebral fracture (mean follow-up 7.4 ± 3.3 years, n =
6,280) and vertebral fractures assessed by radiographs
both at baseline (1990–1993) and at follow-up visit’ be-
tween 1997 and 1999, thoracolumbar radiographs of the
spine were available for 3,469 individuals in a mean
follow-up of 6.4 years.
Measurements
BMD (g/cm
2) of the hip and L2-L4 of the lumbar spine
were measured by dual-energy X-ray absorptiometry
(DXA) using a Lunar DPX densitometry (DPX-L) (Lunar
Radiation, Madison, WI) and reanalyzed with DPX-IQ
software, under standard protocols. Methods, quality
assurance, accuracy, and precision issues of the DXA
measurements have been described previously [21]. The
relative change of BMD from baseline was estimated as the
difference in BMD between assessment periods divided by
the BMD at baseline.
Height (cm) and weight (kg) were measured with a
stadiometer at the initial examination, in standing position
wearing indoor clothes without shoes. Body mass index
(BMI) was computed as weight divided by height (kg/cm
2).
Fracture Follow-up
Information on incident nonvertebral fractures was col-
lected from baseline (1990–1993) until January 1, 2002
(mean follow-up ± SD 7.4 ± 3.3 years, n = 6,280).
Nonvertebral fracture events were retrieved from com-
puterized records of the general practitioners (GPs) in the
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ticipant information in GP records outside the research area
and made an independent review, encoding all reported
events. Subsequently, a medical expert in the ﬁeld reviewed
all coded events for ﬁnal classiﬁcation. We excluded frac-
tures that were considered nonosteoporotic, i.e., caused by
cancer and high trauma, including fractures of the hand,
foot, skull, and face. Subsequently, we analyzed separately
‘‘fragility’’ fractures, which were deﬁned as any fracture of
the hip, pelvis, or proximal humerus that had occurred with
minimal trauma at older age (mean >75 years).
Vertebral Fracture Assessment
Both at baseline and at ﬁrst follow-up, between 1997 and
1999, thoracolumbar radiographs of the spine were ob-
tained. The follow-up radiographs were available for 3,456
individuals, who survived an average of 6.4 (SD = 0.4)
years after the baseline visit and who were still able to
come to our research center. All follow-up radiographs
were scored for the presence of vertebral fracture by the
McCloskey/Kanis method, as described previously [22].
Genotyping
Genomic DNA was extracted from samples of peripheral
venous blood according to standard procedures. Genomic
DNA (1–2 ng) was dispensed into 384-well plates using a
Sciclone ALH3000 pipetting robot (Caliper, Mountain
View, CA). Genotypes were determined using the Taqman
allelic discrimination assay. The Assay-by-Design service
(http://www.appliedbio-systems.com) was used to set up a
Taqman allelic discrimination assay for the COL1PR-1997
polymorphism (primers: Fw, GCCTCCGGAGGGTGTCA,
Rv, AAGGAGAGCAATTCTTACAGGTGTCT; probes:
FAM-CCTGAGGGATGGAA-MGB, VIC-CCTGAAGGA
TGGAAG-MGB. The polymerase chain reaction (PCR)
mixture included 1–2 ng of genomic DNA in a 2 lL volume
and the following reagents: FAM and VIC probes (200 nM),
primers(0.9lM),and2·TaqmanPCRmastermix(ABgene,
Epsom, UK). Reagents were dispensed in a 384-well plate
using the Deerac Equator NS808 (Deerac Fluidics, Dublin,
Ireland).PCRcyclingwasperformedin384-wellPCRplates
in an ABI 9700 system (Applied Biosystems, Foster City,
CA) and consisted of initial denaturation for 15 minutes at
95 C,40cycleswithdenaturationof15secondsat95 C,and
annealingandextensionfor60secondsat60 C.Resultswere
analyzed by the ABI Taqman 7900HT using the sequence
detection system 2.22 software (Applied Biosystems). To
conﬁrm the accuracy of genotyping results, 332 (5%) ran-
domly selected samples were regenotyped with the same
method. No inconsistencies were observed. For Sp1 (in-
tron1) an assay was set up using Primer Express Software
version 2.0 (Applied Biosystems, Foster City, CA). Forward
and reverse primer sequences were 5¢-GTTGTCTAGGT
GCTGGAGGTT-3¢ and 5¢-GGCGAGGGAGGAGAGAA
GG-3¢.ThePCRmixtureincluded5ngofgenomicDNAina
4 lL volume and the following reagents: FAM-CCCGC
CCACATTCCCTGG-MGB probes (250 nM), TET-CCCG
CCCCCATTCCCTGG-MGBprobe(500nM),primers(300
nM), 2· Taqman PCR master mix (Applied Biosystems).
PCR cycling was performed in 384-well PCR plates in the
ABI 9700 PCR system and consisted of initial denaturation
for 15 minutes at 95 C, 40 cycles with denaturation of 15
secondsat95 C,andannealingandextensionfor60seconds
at60 C.Resultswere analyzed by the ABI Taqman7900HT
using the sequence detection system 2.1 software (Applied
Biosystems). To conﬁrm the accuracy of the genotyping
results,332randomlyselectedsamplesweregenotypedfora
second time with the same method. All polymorphisms had
an error rate lower than 1%.
Statistical Analysis
Hardy-Weinberg equilibrium of the COLIA1 polymorphism
genotypes was tested using the GENEPOP package [23].
Linkage disequilibrium (LD) between each pair of alleles at
both polymorphic loci was calculated as D¢ and r
2 [24].
We stratiﬁed all analyses by gender, considering peak
bone mass, changes in BMD, and fractures, following age-
and sex-speciﬁc patterns. Baseline BMD and BMD rate of
change were compared across COLIA1 polymorphisms
using univariate analysis of variance (ANOVA). Correc-
tions were made for age and BMI. Trend analysis assuming
an underlying additive genetic model was done for the
presence of zero, one, or two copies of the associated al-
lele, incorporating the genotype variable as a continuous
term in a general linear regression model. For the analysis
of nonvertebral fracture follow-up data, we computed the
incidence rates of fracture among genotypes and used
Cox’s proportional hazards model, adjusting for age and
BMI to estimate risk of fracture. For vertebral fractures,
odd ratios with 95% conﬁdence intervals (95% CIs) were
calculated using logistic regression models since no data on
the exact time of occurrence could be determined.
We used HaploStats (available at http://www.cran.r-pro-
ject.org/) to estimate the frequency of inferred haplotypes
and investigate the association of haplotypes with BMD and
the risk of fractures.We restricted the analysis to haplotypes
with an inferred frequency of more than 0.02. The ﬁrst
haplotype, which was most frequent, was used as reference.
Signiﬁcant P values were 0.05 or lower. Finally, model
assumptions were veriﬁed and model residuals checked for
goodness-of-ﬁt. SPSS 11.0 (SPSS, Chicago, IL) was used
for the analyses.
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Allele and genotype frequencies of the -1997 G/T and Sp1
polymorphisms were in Hardy-Weinberg equilibrium (P =
0.61 and P = 0.10, respectively). General characteristics of
the study population at baseline and follow-up are shown in
Table 1.
Baseline BMD by COLIA1 Genotypes
In both genders, age, height, weight, and BMI did not
differ signiﬁcantly between genotypes for the -1997 G/T
and Sp1 polymorphisms (data not shown). Table 2 shows
the BMD values according to COLIA1 genotypes in men
and women. Femoral neck BMD was 3.8% lower (mean
difference = 0.03 g/cm
2, P = 0.09) in women who were
homozygous carriers of the Sp1 T allele compared to
noncarriers, with evidence for an allele dose effect (P for
trend = 0.03) (Table 2). No association was found be-
tween the -1997 promoter polymorphism and lumbar
spine BMD or femoral neck BMD in men or women
(Table 2). We did not observe any signiﬁcant association
between the Sp1 and -1997 promoter polymorphisms with
changes in BMD during follow-up in men or women
(Table 2).
Risk of Fracture by COLIA1 Genotypes
The relation between risk of fracture and COLIA1 Sp1
polymorphism is shown in Table 3. Women with two
copies of the T allele of the Sp1 polymorphism had a 2.3
times higher risk of fragility fracture (95% CI 1.4-3.9, P =
0.001). Adjustment for femoral neck BMD did not essen-
tially modify the association. A similar association was
observed in men who were homozygous carriers of the Sp1
T allele, which was borderline signiﬁcant (risk ratio = 2.3,
95% CI 0.9–5.8, P = 0.07). For the -1997 promoter poly-
morphism no association was found with any type of
fracture in either men or women (Table 3).
Haplotype Analysis
High LD exists between the -1997 G/T and Sp1 poly-
morphisms, as assessed by D¢ measure (D¢ = 0.99, r
2 =
0.03). We observed in our population three -1997 G/T, Sp1
G/T haplotype alleles (Fig. 1): haplotype 1 (Gpromoter–
GIntron), 69.0%; haplotype 2 (Gpromoter–TIntron), 17.6%; and
haplotype 3 (Tpromoter–GIntron), 13.4%. Haplotype 4 (Tpro-
moter–TIntron) was not present (Fig. 1). The strong LD be-
tween the -1997 G/T and Sp1 G/T polymorphism and the
virtual nonexistence of haplotype 4 suggests there is ab-
sence of ancestral recombination in the region. We ob-
served a borderline signiﬁcant association (P = 0.06)
between haplotype 2 (Gpromoter–TIntron) and femoral neck
BMD in women. Women who carried haplotype 2 (Gpro-
moter–TIntron) had lower (–0.01 mg/cm
2) femoral neck BMD
compared with those who carried haplotype 1 (Gpromoter–
GIntron).
The relation between risk of fracture and COLIA1
haplotypes is shown in Table 4. Women with haplotype 2
(Gpromoter–TIntron) had a 2.1 times higher relative risk of
fragility fracture (P = 0.03); in men the increase in risk was
2.0 (P = 0.31). These results were essentially unchanged
after adjustment for femoral neck BMD. For haplotype 3
(Tpromoter–GIntron) we found no association with any type of
fracture in either men or women.
Table 1 General characteristics of the study population at baseline and second follow-up
Women Men
Baseline Second follow-up Baseline Second follow-up
Number n = 3,374 n = 1,724 n = 2,452 n = 1,287
Age (years) 68.3 ± 8.2 72.7 ± 6.8 67.6 ± 7.7 72.2 ± 6.5
Height (cm) 161.1 ± 6.8 160.6 ± 6.4 174.6 ± 6.8 174.0 ± 6.7
Weight (kg) 69.3 ± 11.4 70.3 ± 12.2 78.2 ± 10.8 79.5 ± 11.3
BMI (kg/m
2) 26.7 ± 4.1 27.2 ± 4.4 25.6 ± 3.0 26.3 ± 3.2
FN-BMD (g/cm
2)
a 0.83 ± 0.14 0.80 ± 0.13 0.92 ± 0.14 0.90 ± 0.14
Lumbar spine BMD (g/cm
2) 1.03 ± 0.18 - 1.16 ± 0.20 -
FN-BMD change n = 1,527 n = 1,143
FN-BMD change (relative % of baseline year)
b –0.84 ± 1.09 -
Values are means ± SD. Anthropometric measurement based on 5,826 individuals at baseline and 3,011individuals at follow-up
a BMD measurements based on 5,737 individual at baseline and 2,670 individual at second follow-up
b Femoral neck (FN) BMD change was measured between second follow-up and baseline. Second follow-up measurements were performed on
average 6.5 (SD = 0.6) years after baseline
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In this large population-based study, we found that the Sp1
polymorphism inﬂuences the risk of fragility fracture in
elderly women, with a similar yet not signiﬁcant effect in
men. Similarly, women homozygous for the T allele had
3.8% lower BMD at baseline. The -1997 G/T polymor-
phism showed no independent effect on fracture risk or
BMD levels in both genders. The haplotype analysis
showed an association with BMD and fracture in women,
which appeared to be driven by the effect of the Sp1
polymorphism.
A study in Spain [19] showed that the -1997 G/T
polymorphism located in the promoter region of the CO-
Table 2 BMD measurements by COLIA1 genotypes at baseline and follow-up
Promoter -1997 G/T Intron 1 Sp1 G/T
GG GT TT P* GG GT TT P*
Men n = 1,663 n = 494 n =3 7 n = 1,484 n = 655 n =5 5
Femoral neck (g/cm
2) 0.92 ± 0.13 0.92 ± 0.14 0.90 ± 0.14 1.00 0.92 ± 0.14 0.92 ± 0.14 0.90 ± 0.12 0.45
Lumbar spine (g/cm
2) 1.16 ± 0.19 1.17 ± 0.20 1.15 ± 0.22 0.96 1.17 ± 0.19 1.16 ± 0.20 1.16 ± 0.20 0.91
Number n = 668 n = 233 n =1 6 n = 606 n = 293 n =1 8
FN-BMD change (relative % of
baseline year)
–0.46 ± 0.91 –0.36 ± 0.93 –0.38 ± 0.60 0.62 –0.39 ± 0.93 –0.56 ± 0.87 –0.30 ± 0.82 0.01
Women n = 2,157 n = 710 n =5 3 n = 1,971 n = 858 n =9 1
Femoral neck (g/cm
2) 0.83 ± 0.14 0.84 ± 0.13 0.85 ± 0.13 0. 22 0.83 ± 0.13 0.82 ± 0.14 0.80 ± 0.14 0.09**
Lumbar spine (g/cm
2) 1.03 ± 0.18 1.04 ± 0.18 1.01 ± 0.18 0.69 1.04 ± 0.18 1.04 ± 0.19 1.01 ± 0.20 0.52
Number n = 820 n = 298 n =2 4 n = 773 n = 340 n =2 9
FN-BMD change (relative % of
baseline year)
–0.84 ± 1.11 –0.83 ± 1.01 –0.78 ± 1.03 0.85 –0.85 ± 1.08 –0.80 ± 1.04 –0.74 ± 1.49 0.55
Values are expressed as mean ± SD. Adjustments for age and BMI. Femoral neck (FN) BMD change was measured between second follow-up
and baseline
* P for ANOVA.
**For trend linear regression: P = 0.03
Table 3 Risk of fractures by COLIA1 genotypes
COLIA1 genotypes Types of fracture Event (%) Risk ratio (95% CI)
GG GT TT GG (reference) GT vs. reference TT vs. reference
Men
Promoter -1997 G/T
Nonvertebral 147/1952 (7.5) 49/592 (8.3) 1/46 (2.2) 1.0 (reference) 3.18 (0.45–22.74) 3.44 (0.47–29.94)
Fragility 72/1952 (3.7) 14/592 (2.4) 1/46 (1.8) 1.0 (reference) 1.46 (0.20–10.55) 0.94 (0.12.7.14)
Vertebral 100/1056 (9.5) 35/340 (10.3) 3/28 (10.7) 1.0 (reference) 1.07 (0.71–1.61) 1.23 (0.36–4.18)
Intron 1 Sp1 G/T
Nonvertebral 91/1254 (7.3) 39/574 (6.8) 4/44 (9.1) 1.0 (reference) 0.97 (0.71–1.33) 1.40 (0.65–3.00)
Fragility 36/1254 (2.9) 14/574 (2.4) 2/44 (4.5) 1.0 (reference) 0.94 (0.58–1.51) 2.34 (0.94–5.85)
Vertebral 68/719 (9.5) 31/350 (8.9) 2/22 (9.1) 1.0 (reference) 0.83 (0.55–1.24) 1.59 (0.60–4.22)
Women
Promoter -1997 G/T
Nonvertebral 528/2721 (19.4) 182/879 (20.7) 8/63 (12.7) 1.0 (reference) 1.53 (0.76–3.09) 1.66 (0.82–3.36)
Fragility 216/2721 (7.9) 73/879 (8.3) 4/63 (6.3) 1.0 (reference) 1.13 (0.42–3.05) 1.19 (0.44–3.26)
Vertebral 159/1320 (12.0) 52/445 (11.7) 5/35 (14.3) 1.0 (reference) 0.98 (0.70–1.37) 1.31 (0.49–3.45)
Intron 1 Sp1 G/T
Nonvertebral 279/1626 (17.2) 121/710 (17.0) 17/76 (22.4) 1.0 (reference) 1.05 (0.90–1.23) 1.34 (0.92–1.23)
Fragility 98/1626 (6.0) 42/710 (5.9) 10/76 (13.2) 1.0 (reference) 1.01 (0.78–1.31) 2.33 (1.39–3.87)
Vertebral 98/891 (11.0) 51/401 (12.7) 3/34 (8.8) 1.0 (reference) 1.21 (0.88–1.65) 1.37 (0.56–3.35)
Adjustments for age and BMI
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women of Spanish origin. In addition, analysis of com-
pound genotypes of the three studied polymorphisms (-
1997 G/T, Sp1, and -1663 indelT) suggested that the lowest
value for BMD corresponded to GG homozygous at -1997
and heterozygous at the other two loci. Furthermore, in
another report, the same group observed a possible func-
tional mechanism for the -1997 G/T polymorphism [25].
Our population-based study suggests there is no indepen-
dent effect of the -1997 polymorphism on BMD and the
risk of fractures.
Recently, Stewart et al. [26] examined the three poly-
morphisms of the COLIA1 gene in forms of haplotypes in
postmenopausal women. In contrast with our study, they
observed an association between reduced BMD values and
the promoter –1997G/T polymorphism. Since the promoter
-1997G/T polymorphism is in strong LD with the Sp1
polymorphism, the observed association of haplotype 2 is
driven by the SP1 polymorphism.
We showed that the association between fragility frac-
tures and Sp1 polymorphism is signiﬁcant only in women.
We also found that the association between fragility frac-
ture and the Sp1 polymorphism was independent of fem-
oral neck BMD. A possible explanation for an increased
risk of fracture is the different number of fractures between
men and women. There are a higher number of fractures in
women compared to men (13.2% in women and 4.5% in
men). This suggests that other underlying biological
mechanisms beyond BMD levels, such as the role of
microarchitecture and composition of mineral crystals in
bone tissue, might explain the increased fracture risk [11,
27, 28]. Biomechanical testing of bone samples from het-
erozygous individuals with the GT genotype showed re-
duced bone strength compared to the homozygous GG
genotype and a slight reduction in mineralization of bone
[11]. Presence of the T allele in the COLIA1 Sp1 binding
site leads to an abnormal relative level of COLIA1/CO-
LIA2, which may reduce bone quality and quantity [11].
Accordingly, we assume that a weaker network of abnor-
mal collagen cross-linking may generate a three-dimen-
sional unstable condition that may be responsible for its
relatively greater risk of fragility fracture in elderly women
homozygous for the Sp1 T allele. Similarly, it is likely that
the Sp1 polymorphism drives these associations since
evidence of functionality of this polymorphism has been
reported previously.
Fig. 1 Schematic
representation of the COLIA1
gene with the structural-1997 G/
T polymorphism in the
promoter region and G/T Sp1
polymorphism at binding site,
with observed haplotype
frequencies in the Rotterdam
Study
Table 4 Risk of fracture by COLIA1 haplotypes
Types of fracture Men, OR (95% CI) Women, OR (95% CI)
Haplotype 1 Haplotype 2 Haplotype 3 Haplotype 1 Haplotype 2 Haplotype 3
Nonvertebral 1 (reference) 1.29 (0.55–3.02) 0.00 (0.00-¥) 1 (reference) 1.31 (0.83–2.07) 0.61 (0.29–1.29)
Fragility 1 (reference) 2.01 (0.71–5.67) 0.00 (0.00-¥) 1 (reference) 2.12 (1.23–3.66) 0.80 (0.29–2.23)
Vertebral 1 (reference) 1.64 (0.62–4.31) 1.19 (0.35–4.00) 1 (reference) 1.23 (0.51–2.95) 1.31 (0.50–3.42)
Adjustments for age and BMI. Haplotype 1, (Gpromoter–GIntron); haplotype 2, (Gpromoter–TIntron); haplotype 3, (Tpromoter–GIntron)
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Study, which is the largest study examining the Sp1
polymorphism (n = 20,786) in relation to osteoporosis, an
association between the Sp1 polymorphism and a 1.3 times
incident risk of vertebral fractures was also observed. An
effect of the -1997 promoter polymorphism due to power
limitations cannot be fully excluded and should be subject
to study in a larger population like that of GENOMOS.
Our present study has some limitations. Survival bias
may play a role if individuals who were lost to follow-up
were associated to genotype. Considering this selection
bias, a possible relationship of the COLIA1 polymorphisms
with changes in BMD cannot be fully excluded.
In conclusion, we observed an increased risk of fragility
fractures in women carriers of the COLIA1 Sp1 T allele. In
contrast, the -1997 G/T polymorphism by itself appears to
have no inﬂuence on fracture or BMD in postmenopausal
women, though the role of power limitations cannot be
excluded.
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